This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Commercial Packaging

Analytical Laboratory Services

PCI provides fully audited, in-house laboratories in both our European and North America locations offering a range of analytical services to support clients in the development and commercialization of new medicines.

Staffed with expertly qualified analytical chemists, trained and accredited in the most comprehensive laboratory standards, we provide a complete range of resources and responsive services at each stage of the product lifecycle across a wide variety of dosage forms.

Our analytical services include:

  • Stability testing
  • ID testing
  • Import testing
  • Import release testing

Our state-of-the-art facilities feature best in class and fully GMP and ICH compliant analytical equipment enabling our teams to perform simple ID testing and analytical method transfers, through method development and validation, to EU product release and ICH stability testing, ensuring data reliability and regulatory compliance.

Our facilities also include HEPA filtered air handling systems for the analysis of cytotoxic, teratogenic and uncharacterized products, a darkroom for the analysis of light sensitive products, and the capabilities to work with Schedule II-IV controlled substances.

Analytical services are offered on a stand-alone basis or in conjunction with our clinical, commercial and QP services to facilitate a seamless transmission through the drug development cycle.

Our dedicated team of specialists will be happy to discuss our QP Services. Contact us on +1 779-774-1428 (US) or +44 1495 711 222 (UK) or email sales@pciservices.com


PCI Unveils Clinical Center of Excellence

Expanded Clinical Services Facility in Rockford, IL to Support Growth and Flexibility with 30,000 additional sq ft We have officially... View Article

Significant Investments at Ireland Site

PCI Strengthens Position in Europe with Investment in Ireland Latest development at Dublin site positions it at forefront of EU... View Article

x